Intracranial Arterial Diseases
6
0
0
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Cerebral Arteriovenous Malformation With Aneurysm: Epidemiology, Clinical Features, and Prognosis
The Efficacy and Safety of Intracranial Self-expanding DES in Symptomatic Intracranial Atherosclerotic Disease
Analysis of Selective Cerebrovascular Distribution With FDCT in the Angiosuite
Intracranial Stenting in Non-acute Symptomatic Ischemic Stroke
Researching AXIUM Coiling Experience and Recanalization (RACER)
Rosuvastatin Treatment for Intracranial Arterial Stenosis Based on Magnetic Resonance Angiography